story of the week
Nivolumab Plus Gemcitabine–Cisplatin for Advanced Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma
N. Engl. J. Med 2023 Oct 22;[EPub Ahead of Print], MS van der Heijden, G Sonpavde, T Powles, A Necchi, M Burotto, M Schenker, JP Sade, A Bamias, P Beuzeboc, J Bedke, J Oldenburg, G Chatta, Y Ürün, D Ye, Z He, BP Valderrama, JH Ku, Y Tomita, J Filian, L Wang, D Purcea, MY Patel, F Nasroulah, MD GalskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.